Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer

Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer

Abstract Background The DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer. Despite the DYNAMIC trial’s assertion that a ctDNA-guided approach could minimize the use of adjuvant treatment without compromising recurrence-...

Full description

Bibliographic Details
Main Authors: Timothée Olivier, Alyson Haslam, Vinay Prasad
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Medicine
Subjects:
Adjuvant therapy
Oncology
Molecular test
Colon cancer
ctDNA
Evidence-based medicine
Online Access:https://doi.org/10.1186/s12916-023-03037-9

Internet

https://doi.org/10.1186/s12916-023-03037-9

Similar Items